Nephrocare Health Services Limited

Axis Direct bullish on Dr Lal PathLabs, Vijaya Diagnostic and Nephrocare, assigns 'Buy' ratings with up to...
Moneycontrol.com · 12 Oct 2026
Nephrocare Health Services (NSEI:NEPHROPLUS) Stock Forecast & Analyst Predictions
Simply Wall Street · 09 Oct 2026
Nephrocare investors to sell 9% stake for Rs 650 crore under block deal
Medical Buyer · 25 Sep 2026
Nephrocare shares tumble 5% | What’s driving the decline?
Livemint · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.